Displaying 1 to 20 of 64 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Articulinx Inc Medical device company developing a novel minimally-invasive approach for the treatment of osteoarthritis |
United States | N/A |
||
|
|
Asante Solutions Inc Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics. |
United States | N/A |
||
|
|
Astute Medical Inc Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers |
United States | 1 Mar 2011 | Series B |
|
|
|
Astute Medical Inc Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers |
United States | 1 Jun 2012 | Series C |
|
|
|
Astute Medical Inc Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers |
United States | 1 May 2008 | Series A |
|
|
|
Avedro Inc A medical device company focused on vision correctional devices and has developed innovative ophthalmology solutions for the Lasik and myopia markets. |
United States | 1 Jul 2011 | Series C |
|
|
|
Axogen Inc Developmer of treatment options for the repair of peripheral nerve injuries. |
United States | N/A Active |
||
|
|
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. |
United States | N/A |
||
|
|
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Jan 2008 | Series B |
|
|
|
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Apr 2011 | Series C |
|
|
|
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Jun 2012 | Series D |
|
|
|
BioParadox Inc Developing a novel therapy for cardiovascular disease. |
United States | N/A |
||
|
|
C2 Therapeutics Inc |
United States | N/A |
||
|
|
CardioThoracic Systems Inc |
N/A |
|||
|
|
CAVU Medical Inc |
United States | N/A |
||
|
|
CryoVascular Systems Inc Medical device company for peripheral arterial disease. |
United States | N/A |
||
|
|
EBR Systems Inc A venture-backed clinical stage company founded to develop implantable systems for wireless tissue stimulation |
United States | 1 Jun 2008 | Series C |
|
|
|
EBR Systems Inc A venture-backed clinical stage company founded to develop implantable systems for wireless tissue stimulation |
United States | 1 Oct 2005 | Venture |
|
|
|
EndoGastric Solutions Inc |
United States | 1 Jun 2012 | Series F Initial investment. Round participant. Active |
|
|
|
EndoGastric Solutions Inc |
United States | 30 Jun 2009 | Venture Initial investment. Round participant. Active |